PinkDx
INDIANAPOLIS, IN · Biotechnology · 18 employees
PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive impact on their lives. The company's first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological c
Funding history
- Series A — $5.0M — Jan 2025
- Series A — $40.0M — Apr 2024
Recent signals
- Jan 24, 2025: Raised $5.0M in Series A
- Nov 04, 2024: PinkDx Appoints Marra S. Francis, M.D., F.A.C.O.G., as Chief Medical Officer
- Apr 25, 2024: Raised $40.0M in Series A
See plans & pricing → Track PinkDx’s funding, hiring, and signals — with verified contacts — on Fundz.